Table 2.
Summary of patients receiving corticosteroids as additional treatment
| Study | Patient characteristics | Aspirin | IVIG | Corticosteroid | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total patients | Therapy group | Sex (male %) | Age (year) | Therapy day | mg/kg per day | g/kg per dose | No. of doses | Drug preparation | Dosage (mg/kg per day) | Duration of therapy (days) | |
| Ogata S et al. [19] | 27 | 14 | – | 2.5 | 9 | 30 | 2 | 1 | IVMP | 30 | 3 |
| Miura et al. [14] | 15 | 7 | 66.7 | 2.6 | 9 | – | 2 | 1 | IVMP | 30 | 3 |
| Hashino et al. [7] | 17 | 9 | – | 6.3 | 9 | 30 | 1 | 1 | IVMP | 20 | 3 |
| Furukawa et al. [6] | 63 | 44 | 54 | 2.4 | 8 | 30 | 1–2 | 3 | IVMP | 30 | 3 |